Health Canada Approves Two Formulations Of Celltrion’s Stelara Biosimilar
This Marks The Third Approved Stelara Biosimilar In Canada
Following past approvals for Alvotech and Amgen, Health Canada greenlighted Celltrion’s Stelara biosimilar in most of the relevant indications, moving it ahead of Alvotech’s product.
